422 reports of this reaction
1.5% of all FAMILY WELLNESS CLOTRIMAZOLE reports
#15 most reported adverse reaction
THERAPEUTIC PRODUCT EFFECT INCOMPLETE is the #15 most commonly reported adverse reaction for FAMILY WELLNESS CLOTRIMAZOLE, manufactured by AARNA USA INC. There are 422 FDA adverse event reports linking FAMILY WELLNESS CLOTRIMAZOLE to THERAPEUTIC PRODUCT EFFECT INCOMPLETE. This represents approximately 1.5% of all 28,516 adverse event reports for this drug.
Patients taking FAMILY WELLNESS CLOTRIMAZOLE who experience therapeutic product effect incomplete should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
THERAPEUTIC PRODUCT EFFECT INCOMPLETE is a less commonly reported adverse event for FAMILY WELLNESS CLOTRIMAZOLE, but still significant enough to appear in the safety profile.
In addition to therapeutic product effect incomplete, the following adverse reactions have been reported for FAMILY WELLNESS CLOTRIMAZOLE:
The following drugs have also been linked to therapeutic product effect incomplete in FDA adverse event reports:
THERAPEUTIC PRODUCT EFFECT INCOMPLETE has been reported as an adverse event in 422 FDA reports for FAMILY WELLNESS CLOTRIMAZOLE. This does not prove causation, but indicates an association observed in post-market surveillance data.
THERAPEUTIC PRODUCT EFFECT INCOMPLETE accounts for approximately 1.5% of all adverse event reports for FAMILY WELLNESS CLOTRIMAZOLE, making it a notable side effect.
If you experience therapeutic product effect incomplete while taking FAMILY WELLNESS CLOTRIMAZOLE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.